We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Asthma Relapse Found in Many Young Adults

By HospiMedica staff writers
Posted on 02 Jun 2003
A new study has found that one-third of teenagers with a childhood history of asthma who no longer have symptoms at age 18 will have a recurrence of asthma symptoms by the time they are 26. More...
The study was presented at the international conference of the American Thoracic Society in Seattle (WA, USA).

The study involved 1,037 young adults (to age 26) in New Zealand, who had detailed respiratory histories every two years until age 15, then one at 18, 21, and 26 years of age. Of this group, 176 had diagnosed asthma at ages 9, 11, 13, and 15. Of these, 68 had no asthma symptoms at age 18, but 16 (24%) had asthma symptoms when they were 21 and the symptoms persisted in eight of them until age 26. Of the 52 who had no symptoms at 21 years, eight reported symptoms at age 26. Thus, a total of 24 of the 68 (35%) with no asthma symptoms at age 18 experienced relapses by age 21 or 26.

Those who are at greatest risk of relapsing are young adults who are highly allergic or have bronchial hyper-responsiveness, which can be measured in a pulmonary function laboratory. However, only 26% of those who relapsed in the study were shown positive for bronchial hyper-responsiveness.

"It is likely that during adolescence, the asthma subsides to the point where airway inflammation is minimal and does not cause symptoms,” said lead researcher Robin Taylor, M.D., of the University of Otago School of Medicine in Dunedin (New Zealand). "Patients who have a relapse likely have had a change in environment that provokes airway inflammation to the point where asthma symptoms recur.” Dr. Taylor noted that the study focused on 18-year-olds because they are often being assessed medically for employment reasons.




Related Links:
U. of Otago

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.